BC Week In Review | Sep 1, 2017
Company News

RegenxBio acquiring gene therapy play Dimension

RegenxBio Inc. (NASDAQ:RGNX) will acquire Dimension Therapeutics Inc. (NASDAQ:DMTX) in a stock deal. For each share held, Dimension shareholders will receive 0.1573 RegenxBio shares, which the companies say implies a value of $3.41 per Dimension...
BC Extra | Aug 25, 2017
Company News

RegenxBio acquiring gene therapy play Dimension

RegenxBio Inc. (NASDAQ:RGNX) will acquire Dimension Therapeutics Inc. (NASDAQ:DMTX) in a stock deal. For each share held, Dimension shareholders will receive 0.1573 RegenxBio shares, which the companies say implies a value of $3.41 per Dimension...
BioCentury | May 25, 2015
Emerging Company Profile

Dimension's intentions

With an industry veteran at the helm and its lead program partnered and paid for, Dimension Therapeutics Inc. aims to develop safer and more potent gene therapies by packaging as many gene copies into capsids...
Items per page:
1 - 3 of 3